Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-α. Results of a phase I clinical trial
Randall E. Merchant, Daniel W. McVicar, Lynn H. Merchant, Harold F. YoungVolume:
12
Language:
english
Pages:
9
DOI:
10.1007/bf00172459
Date:
January, 1992
File:
PDF, 620 KB
english, 1992